| Kathleen Shelton, | |
|
3365 Hunting Hills Ct, Lexington, KY 40515-1322 | |
| (859) 576-4807 | |
| Not Available |
| Full Name | Kathleen Shelton |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3365 Hunting Hills Ct, Lexington, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003346503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 0652 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Shelton, 3365 Hunting Hills Ct, Lexington, KY 40515-1322 Ph: (859) 576-4807 | Kathleen Shelton, 3365 Hunting Hills Ct, Lexington, KY 40515-1322 Ph: (859) 576-4807 |
News Archive
Researchers have tracked a cell-to-cell signaling pathway that designates the future location of the ear's sensory organs in embryonic mice. The scientists succeeded in activating this signal more widely across the embryonic tissue that becomes the inner ear. Patches of sensory structures began growing in spots where they don't normally appear.
ORIX USA Health and Life Sciences has completed an investment into Translational Drug Development (TD2) through the purchase of equity from the Translational Genomics Research Institute (TGen).
MannKind Corporation today announced the pricing of its previously announced offering of $100 million aggregate principal amount of Senior Convertible Notes due 2015 (the "Notes"). The Notes will be offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), by the financial institutions that are the initial purchasers of the notes.
Vittorio Gallo, PhD, Director of the Center for Neuroscience Research at Children's National Health System, and other researchers have found a "potentially novel therapeutic target" to reduce the rate of deterioration and to promote growth of brain cells damaged by multiple sclerosis (MS). Current therapies can be effective in patients with relapsing MS, but have little impact in promoting tissue growth.
UK scientists have found no evidence to suggest that children whose mothers lived close to mobile phone base stations during pregnancy face an increased risk of early childhood cancers.
› Verified 5 days ago
Mrs. Jessica Sanders Roberts, M.A, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2412 Greatstone Pt, Lexington, KY 40504 Phone: 859-224-4081 | |
Mrs. Erica Keller Musgrave, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 882 Mcmeekin Pl, Lexington, KY 40502 Phone: 859-619-5259 | |
Melena Dailey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2412 Greatstone Pt, Lexington, KY 40504 Phone: 859-224-4081 | |
Barbara Shaw, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Mason Headley Rd, Lexington, KY 40504 Phone: 859-276-1083 | |
Emily Davis, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3221 Summit Square Pl Ste 150, Lexington, KY 40509 Phone: 859-353-3666 | |
Christina Johnson, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1165 Monarch St, Lexington, KY 40513 Phone: 859-335-7980 |